JPRN-UMIN000002076
Completed
未知
Aripiprazole research over schizophrenia patients (both on first episode and recurrence) about its efficacy and influence on cognitive function - Aripiprazole research over schizophrenia patients (both on first episode and recurrence) about its efficacy and influence on cognitive function
Conditionsschizophrenia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- schizophrenia
- Sponsor
- Kyoto University Hospital
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •patients using epinephrine patients with allergic reaction to aripiprazole before diabetic patients and patients who have history of suffering from diabetes patients with (or, with the possibility of) pregnancy patients taking other antipsychotics other patients not suitable for this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
Treatment of Schizophrenia with Aripiprazole. A one year open-label study.SchizophreniaMental Health - SchizophreniaACTRN12605000394640Associate Professor Krishna Vaddadi40
Not yet recruiting
Not Applicable
Aripiprazole dose reduction in stable schizophreniaJPRN-UMIN000051193Keio University100
Completed
Phase 4
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social AnxietySchizophreniaSchizoaffective DisorderSocial Anxiety DisorderNCT00177008University of Medicine and Dentistry of New Jersey18
Completed
Not Applicable
Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar DisorderSchizophreniaBipolar DisorderNCT00216723Korea Otsuka Pharmaceutical Co., Ltd.3,000
Completed
Not Applicable
Effect of aripiperazole on psychiatric symptoms in patients with Parkinson diseaseParkinson's diseaseJPRN-UMIN000007711Parkinson Study Group Japan20